Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis

Fig. 1

High expression of SRSF9 in HCC tissues and cell lines. A mRNA level of SRSF9 in 374 HCC tissues and 50 paratumor tissues based on TCGA database; B mRNA level of SRSF9 in HCC and normal tissues from laboratory samples; C mRNA level of SRSF9 in normal liver cells (L02), a hepatoblastoma cell line (HepG2), and HCC cell lines (Huh-7 and Hep3B); D IHC results for SRSF9 in HCC and normal tissues from laboratory samples; E Correlation between SRSF9 expression and 1-year, 3-year, and 5-year survival rates of patients with HCC based on TCGA database. ***P < 0.001, ****P < 0.0001 versus the normal group (or L02 group). AUC > 0.7 indicated a high accuracy. AUC area under the curve

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us